NCT01766960View on ClinicalTrials.gov

Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

June 30, 2014

Conditions
Fatty Liver
Interventions
OTHER

High fat meal

A high fat breakfast will be administered to induce gall bladder emptying.

DRUG

Morphine

Five milligrams of intravenous morphine will be administered.

Trial Locations (1)

27599

North Carolina Clinical and Translational Research Center, Chapel Hill

All Listed Sponsors
collaborator

University of North Carolina, Greensboro

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT01766960 - Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver Disease | Biotech Hunter | Biotech Hunter